SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001683168-17-000777
Filing Date
2017-04-03
Accepted
2017-04-03 17:00:09
Documents
1
Group Members
JAFCO CO., LTD.JAFCO SUPER V4 INVESTMENT LIMITED PARTNERSHIP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G jafco_13g.htm SC 13G 62351
  Complete submission text file 0001683168-17-000777.txt   64262
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88625 | Film No.: 17735002
SIC: 8071 Services-Medical Laboratories

Mailing Address OTEMACHI FIRST SQUARE WEST TOWER 11F,1-5-1,OTEMACHI CHIYODA-KU TOKYO M0 100-0004
Business Address OTEMACHI FIRST SQUARE WEST TOWER 11F,1-5-1,OTEMACHI CHIYODA-KU TOKYO M0 100-0004 812-3-5223-7506
JAFCO SV4 Investment Limited Partnership (Filed by) CIK: 0001702481 (see all company filings)

IRS No.: 981107135 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13G